UBS Maintains Buy on AbbVie, Raises Price Target to $96

UBS maintains AbbVie (NYSE:ABBV) with a Buy and raises the price target from $79 to $96.

Benzinga · 11/19/2019 12:16

UBS maintains AbbVie (NYSE:ABBV) with a Buy and raises the price target from $79 to $96.